EUVIMEDEUVIMED entdecken
Open Access

Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens

Emily S Clark, Greta Garrido, Agata Levay, Brett Schrand, Eli Gilboa iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiaf593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Emily S Clark und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Sylvester Comprehensive Cancer Center, Miller School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8+ T-cell responses are an important component of a protective immune response in many pathogenic infections, including HIV and Herpesviridae such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV). Identification of pathogen-encoded protective antigens, antigenic heterogeneity, and progressive immune dysfunction are major barriers facing the development of effective CD8+ T-cell–targeted vaccines. Here we tested the hypothesis that pathogen-infected cells can be sensitized to vaccination against host-derived antigens presented by the infected cells with reduced expression of TAP (transporter associated with antigen processing). In this study, we show the following: first, natural or targeted downregulation of TAP in CMV- and EBV- or HIV-infected cells, respectively, leads to the presentation of a cell-encoded nonmutated cryptic epitope, initially described in tumor cells with reduced TAP expression; second, peripheral blood mononuclear cell–derived CD8+ T cells enriched for multiple TAP downregulation–induced epitopes recognize TAPlow CMV-, EBV-, and HIV-infected cells, leading to the depletion of TAPlow-infected cells and the expression of activation markers in the T cells. This study describes a prototype of a universal drug formulation to vaccinate against tumors and pathogen-infected cells, dispensing with the need to identify pathogen- or tumor-specific antigenic targets and obviating the limitations associated with antigenic heterogeneity and immune dysfunction characteristic of pathogens such as HIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesHumansHerpesvirus 4, HumanCytomegalovirusATP-Binding Cassette TransportersVaccinationAntigen PresentationHIV InfectionsEpstein-Barr Virus InfectionsCytomegalovirus Infections

Stichwörter der Autor:innen

CD8+ T cellsHIVTAP downregulation–induced antigensantibody targetingpeptide transporter TAPsiRNA

Substanzen

ATP-Binding Cassette Transporterstransporter associated with antigen processing (TAP)

Autor:innen und Institutionen

  • Department of Microbiology and Immunology.
  • Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida.

ORCID-Profile: Eli Gilboa

Förderung

  • NIAID NIH HHS
  • Sylvester Comprehensive Cancer Center
  • Miller School of Medicine

Zitieren

APA

Clark, E. S., Garrido, G., Levay, A., Schrand, B., & Gilboa, E. (2026). Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf593

Vancouver

Clark ES, Garrido G, Levay A, Schrand B, Gilboa E. Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf593

BibTeX
@article{Clark2026,
  author = {Clark, Emily S and Garrido, Greta and Levay, Agata and Schrand, Brett and Gilboa, Eli},
  title = {Vaccination Against Pathogens Targeting Cell-Derived Cryptic Antigens},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiaf593}
}
Kostenlos starten →